AllerFund I

Amulet is a company focused on enhancing food safety by addressing hidden threats within the food system. It operates two primary brands: Allergy Amulet and Amulet Scientific. Allergy Amulet provides consumers with a portable detection system that identifies potentially life-threatening allergenic ingredients in food, allowing users to make informed choices about their meals. Meanwhile, Amulet Scientific caters to businesses and manufacturers by offering a comprehensive detection platform that identifies various molecular targets, including food toxins and environmental contaminants. This dual approach enables both consumers and food producers to effectively monitor and ensure the safety of their food supply.

ATANIS Biotech is a biotechnology company focused on advancing clinical allergy research and developing diagnostic assays. The company aims to enhance and simplify the standard of care for allergy diagnosis through its innovative functional cell-based assay. This novel approach not only streamlines the allergy diagnosis process but also predicts the effectiveness of various treatment options. By providing a reliable tool for functional allergy screening, ATANIS Biotech seeks to improve patient outcomes and support healthcare providers in managing allergy-related conditions more effectively.

IgGenix, Inc. is a biotechnology company focused on developing an innovative antibody therapeutics platform aimed at treating food and non-food allergies, as well as other severe allergic conditions. The company specializes in isolating and transforming allergen-specific IgE antibodies into IgG antibodies, which are designed to alleviate and potentially prevent allergic reactions. By capturing and analyzing rare human B cells that express allergen-binding antibodies, IgGenix engineers these antibodies to incorporate immune-modulating activities derived from the IgG class, thereby enhancing their ability to suppress allergic responses. Founded in 2019 and based in South San Francisco, California, IgGenix is dedicated to addressing the challenges posed by life-threatening allergic reactions through its advanced therapeutic solutions.

Alladapt Immunotherapeutics, founded in 2018 and based in Menlo Park, California, is a privately held biopharmaceutical company dedicated to developing therapeutics for food allergy treatment. Its lead product, ADP101, is an oral immunotherapy designed to mitigate allergic reactions triggered by multiple common allergens, offering a broad-spectrum solution for patients with various food allergies.

IgGenix, Inc. is a biotechnology company focused on developing an innovative antibody therapeutics platform aimed at treating food and non-food allergies, as well as other severe allergic conditions. The company specializes in isolating and transforming allergen-specific IgE antibodies into IgG antibodies, which are designed to alleviate and potentially prevent allergic reactions. By capturing and analyzing rare human B cells that express allergen-binding antibodies, IgGenix engineers these antibodies to incorporate immune-modulating activities derived from the IgG class, thereby enhancing their ability to suppress allergic responses. Founded in 2019 and based in South San Francisco, California, IgGenix is dedicated to addressing the challenges posed by life-threatening allergic reactions through its advanced therapeutic solutions.

Bryn Pharma LLC is a biotechnology company based in Raleigh, North Carolina, that specializes in the research and development of an innovative bi-dose intranasal device designed for the administration of epinephrine in emergency situations related to anaphylaxis. This needle-free nasal solution serves as an alternative to traditional epinephrine auto-injectors, offering a portable and easy-to-use option for patients. The device is designed to be simple enough for individuals without any medical training to operate, making it accessible for those at risk of severe allergic reactions. Established in 2017 and previously known as Epi-Now, LLC, Bryn Pharma aims to enhance the treatment experience for patients facing allergic emergencies.

Allergy Amulet Inc. is a Madison, Wisconsin-based company that specializes in the manufacture and sale of consumer food allergen sensors. Founded in 2016, the company has developed the Allergy Amulet, which is recognized as the world's smallest and fastest sensor for detecting common allergenic ingredients in food. This innovative device caters to a wide audience, including families, individuals, children, and businesses, allowing users to test food for allergens in seconds. Its sleek and portable design enables users to carry it conveniently on a keychain, necklace, or wristband, promoting safety and peace of mind for those affected by food allergies. With food allergies impacting approximately 32 million Americans and hundreds of millions globally, Allergy Amulet aims to enhance the quality of life for individuals with food allergies or intolerances.